Cargando…
Antibodies inside of a cell can change its outside: Can intrabodies provide a new therapeutic paradigm?
Challenges posed by complex diseases such as cancer, chronic viral infections, neurodegenerative disorders and many others have forced researchers to think beyond classic small molecule drugs, exploring new therapeutic strategies such as therapy with RNAi, CRISPR/Cas9 or antibody therapies as single...
Autores principales: | Marschall, Andrea L.J., Dübel, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990636/ https://www.ncbi.nlm.nih.gov/pubmed/27570612 http://dx.doi.org/10.1016/j.csbj.2016.07.003 |
Ejemplares similares
-
Specific in vivo knockdown of protein function by intrabodies
por: Marschall, Andrea LJ, et al.
Publicado: (2015) -
Functional knock down of VCAM1 in mice mediated by endoplasmatic reticulum retained intrabodies
por: Marschall, Andrea LJ, et al.
Publicado: (2014) -
Heterochromatin and gene positioning: inside, outside, any side?
por: Jost, K. Laurence, et al.
Publicado: (2012) -
The outside edge: how outsiders can succeed in a world made by insiders
por: Kelsey, Robert
Publicado: (2015) -
Confessions of a baboon watcher: from inside to outside the paradigm
por: Strum, Shirley C.
Publicado: (2023)